Quantcast Pharmaceutical Industry News - Congoo
Log In
  COMPLETE INDUSTRY LIST >> PHARMACEUTICAL INDUSTRY    Get our Pharmaceutical Industry daily Briefing     
Advertising industry
Aerospace & defense
Aerospace related
Airline industry
Automotive industry
Biological sciences
Book publishing
Broadcasting industry
Business related
Cable industry
Chemicals industry
Clothing industry
Communications equipment
Computer games
Computer security
Corporate finance
Corporate governance
Crime & Punishment
Database industry
Digital television
Emerging markets
Engineering Industry
Engineering General
Enterprise computing
Equity markets
European business
Fed watch
Finance news
Firearms industry
Food industry
Forex markets
Fund management
Graphics industry
Hospitality industry
Human resources
Human rights
Human sciences
Imaging equipment
Insurance industry
Internet consultancies
Internet Europe
Internet news
IP and patents
Job markets
Knowledge management
Law related
Leisure goods
Mergers & acquisitions
Metals industry
Mining and metals
Mobile industry
Mortgage industry
Movie business
Music business
Mutual funds
Newspaper publishing
Oil & gas
Online banking
Online broker
Online content
Online information
Online legal issues
Online marketing
Online portals
Open source
Packaging & paper
Packaging related
PC industry
PC software
Personal data privacy
Personal finance
Personal technology
Pharmaceutical Industry
Physical Sciences
Plastics industry
Public health
Real Estate industry
Retail investor
Retail sector
Securities industry
Semiconductor industry
Shipping industry
Silicon Valley
Small business
Software downloads
Space science
Stock Exchanges
Tech stocks
Technology news
Telecom industry
Textiles related
Tobacco industry
Transportation industry
Transportation related
Travel industry
UK law
US education
US immigration
US politics
US security
US social policy
Utilities News
Venture Capital
Web developer
Web services
Webmaster tips
Website owner
Windows OS
Wireless sector
XML & metadata

Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment   - 5 Hours ago
PR Newswire SAN DIEGO, Sept. 2, 2014 SAN DIEGO , Sept. 2, 2014 /PRNewswire/ --  Mast Therapeutics, Inc . (NYSE MKT: MSTX) today announced that the Company's Chief Executive Officer, Brian M. Culley
all 20 news articles >>

Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with   - 5 Hours ago
SOURCE Elbit Imaging Ltd. TEL AVIV, Israel Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF) announced today following the Company's announcement dated August 19, 2014 Under the Agreements,
all 2 news articles >>

ESC Hot Line: Data Reports NVAF Patients Taking Pradaxa® (dabigatran etexilate mesylate)   - 4 Hours ago
RIDGEFIELD, Conn., Sept. 2, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from a new post-hoc sub-analysis of the pivotal phase III RE-LY™ trial assessing renal
all 4 news articles >>

The 16th Annual Hyundai Hope On Wheels Program Announces Goal To Surpass $87 Million   - 4 Hours ago
SOURCE Hyundai Hyundai Hope On Wheels will host its fifth annual national September is Childhood Cancer Awareness Month campaign. The nonprofit plans to award $9 million in pediatric cancer research

Looking Younger, Step by Step: Boston Plastic Surgery Practice Documents a Patient's   - 4 Hours ago
Boston Plastic Surgery demonstrates the dramatic difference a year of injectable treatments makes. PR Newswire BOSTON, Sept. 2, 2014 BOSTON , Sept. 2, 2014 /PRNewswire/ -- Documenting a year-long
all 1 news articles >>

VentiRx Pharmaceuticals Provides Corporate and Clinical Update   - 5 Hours ago
- Management Team, Funding, Immunotherapy Trials - PR Newswire SEATTLE, Sept. 2, 2014 SEATTLE , Sept. 2, 2014 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical

Your sponsored post can go right here! Sponsored

Congoo’s B2B information portal now receives over 1 million visits per month.  Congoo provides a highly influential audience comprehensive news and information within their industry.  Reach a coveted audience of senior executives, affluent males and opinion leaders. Get the Media Kit

Novel Approach to Hysterectomy Surgery Preserves Vital Support Structures, Reduces   - 4 Hours ago
SOURCE Daryoosh Samimi LOS ANGELES Traditional hysterectomy surgeries have always been known to lead to unpredictable results, but medical science has been slow to address this patient safety issue.
all 1 news articles >>

RVX-208 Leads to a 77% Relative Risk Reduction of Major Adverse Cardiovascular Events   - 4 Hours ago
PR Newswire BARCELONA, Spain and CALGARY, AB, Sept. 2, 2014 Presented in 'State of the Art and Featured Research Session' at the 2014 European Society of Cardiology Congress TSX Exchange
all 1 news articles >>

Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To   - 4 Hours ago
First Marketing Authorization Application for an Oncolytic Immunotherapy in the European Union PR Newswire THOUSAND OAKS, Calif., Sept. 2, 2014 THOUSAND OAKS, Calif. , Sept. 2, 2014 /PRNewswire/
all 1 news articles >>

Ernst & Young - The right transaction Sponsored
No matter what the size of your company, where it is located or the business you are in, transactions can help your company grow, prosper or reinvent itself. The Ernst and Young Transaction professionals can play a critical role at every step of the deal lifecycle.  Learn More

Albemarle completes sale of antioxidant, ibuprofen and propofol businesses to SI   - 5 Hours ago
BATON ROUGE, La., Sept. 2, 2014 /PRNewswire/ -- Albemarle Corp About Albemarle Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading global developer, manufacturer, and marketer
all 7 news articles >>

Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and   - 4 Hours ago
SOURCE Xencor, Inc. MONROVIA, Calif. "Debra's expertise in biologics clinical development and medical affairs will be of great value to Xencor as we anticipate advancing the clinical development of
all 1 news articles >>

ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices   - 5 Hours ago
PR Newswire SAN DIEGO, Sept. 2, 2014 SAN DIEGO , Sept. 2, 2014 /PRNewswire/ -- ResMed (NYSE: RMD) has introduced the Astral™ 100 and Astral™ 150 devices in the United States . The Astral platform

American Express takes you places Sponsored
The Preferred Rewards Gold Card takes you places. And shows you’ve arrived. Enjoy Gold Card benefits and access while you earn travel rewards fast. Earn 10,000 Membership Rewards® bonus points redeemable for rewards after your first purchase.  Learn More

Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG   - 4 Hours ago
SOURCE Boston Scientific Corporation MARLBOROUGH, Mass. The addition of the Bayer Interventional strong commercial organization and innovative technologies supports the Boston Scientific strategy to

MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat   - 4 Hours ago
Data from Multi-Center, Placebo-Controlled Study Anticipated in Q1 2015 PR Newswire SAN DIEGO, Sept. 2, 2014 SAN DIEGO , Sept. 2, 2014 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology

Volcano Corporation Presentation At Morgan Stanley Conference To Be Webcast   - 5 Hours ago
PR Newswire SAN DIEGO, Sept. 2, 2014 SAN DIEGO , Sept. 2, 2014 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global

VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337),   - 5 Hours ago
SEATTLE, Sept. 2, 2014 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8)
all 1 news articles >>

Millennium Laboratories Changes Name To Millennium Health, Reflecting Evolution   - 5 Hours ago
PR Newswire SAN DIEGO, Sept. 2, 2014 SAN DIEGO , Sept. 2, 2014 /PRNewswire/ -- Millennium Laboratories has changed its name to Millennium Health, a move that better reflects the company's market

Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production   - 4 Hours ago
SAN CARLOS, Calif., Sept. 2, 2014 /PRNewswire/ --  Intrexon Corporation ( XON ), a leader in synthetic biology, today announced that it has entered into an Exclusive Channel Collaboration (ECC) with Sanofi
all 1 news articles >>

Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent   - 4 Hours ago
SOURCE Orexigen Therapeutics, Inc. - Patent Protection for NB32 for Treating Insulin Resistance - SAN DIEGO U.S. Patent No. 8,815,889 claims methods for treating insulin resistance using a composition

Veracyte to Present at the Morgan Stanley Global Healthcare Unplugged Conference   - 5 Hours ago
SOURCE Veracyte SOUTH SAN FRANCISCO, Calif. The live audio webcast and subsequent replay may be accessed by visiting Veracyte's website at http://investor.veracyte.com. Please connect to the website at

Celsion Announces Enrollment of First Patient in Global Phase III OPTIMA Study of   - 5 Hours ago
Kyungpook National University Hospital in South Korea Treats the First Patient in the 14 Country, 100 Site Global Study Study Designed to Support Registration in Major Liver Cancer Markets Worldwide

Galmed Pharmaceuticals Completes Two Chronic Toxicology Studies and Reports No Significant   - 4 Hours ago
SOURCE Galmed Pharmaceuticals Ltd. TEL-AVIV, Israel In a six-month toxicology study in rats, testing a maximum aramchol dose of 1,000 mg/kg per day, WIL Research did not observe any treatment-related

Cryoport to Present at the Aegis Healthcare & Technology Conference on September   - 4 Hours ago
SOURCE Cryoport, Inc. LAKE FOREST, Calif. During his presentation at the conference, Mr. Stefanovich will discuss the ways in which Cryoport is experiencing significant interest and demand for its

Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial   - 5 Hours ago
PR Newswire SAN DIEGO, Sept. 2, 2014 SAN DIEGO , Sept. 2, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that the US Food and Drug Administration (FDA) has granted

Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser   - 4 Hours ago
SOURCE Frost & Sullivan Novilase minimizes the loss of surrounding breast tissues and reduces retreatment rates MOUNTAIN VIEW, Calif., Sept. 2, 2014 /PRNewswire/ -- Based on its recent analysis of
*Votes may take up to 30 minutes to influence article rank order
Featured Members
Sarah Taylor Sarah Taylor
Pharma Industry
Frank Forney Frank Forney
Pharma Industry
Melissa Lowenstein Melissa Lowenstein
Pharma Industry
John Caminis John Caminis
Vice President Clinical Development
Pharma Industry

  Add your Profile
  View more profiles


Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2014 Congoo.com. All Rights Reserved.